• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
When Is Genome Sequencing Advisable?

When Is Genome Sequencing Advisable?

by Michael Schubert, PhD | Nov 25, 2024 | Clinical Diagnostics Insider, Emerging Tests-dtet, Testing Trends-dtet

With patient and provider demand for WGS on the rise, what should laboratorians know about ordering and interpreting this testing?

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Expert Q&A: What’s Next in Next-Generation Sequencing?

Expert Q&A: What’s Next in Next-Generation Sequencing?

by Rachel Muenz | Nov 24, 2023 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Inside the Diagnostics Industry-dtet, Testing Trends-dtet

Crystal Girod, MSc, of Beckman Coulter Life Sciences discusses recent developments in NGS and their impact on clinical diagnostics.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Which Test? Choosing the Best Approach to Diagnosing Rare Disease

Which Test? Choosing the Best Approach to Diagnosing Rare Disease

by Michael Schubert, PhD | Sep 28, 2023 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet, Testing Trends-dtet

Genomic sequencing is almost twice as likely to yield a diagnostic result, but lags behind panel testing in speed, cost, and concordance.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
ACMG Statements Highlight Ongoing Concerns around Polygenic Risk Scores

ACMG Statements Highlight Ongoing Concerns around Polygenic Risk Scores

by Miriam Bergeret, MSc | May 3, 2023 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Special Focus-dtet

Though there are currently no clinical guidelines for their use, PRSs are being widely used in health care.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Tempus Partners to Advance Genomic Cancer Testing

Tempus Partners to Advance Genomic Cancer Testing

by Glenn S. Demby | Jun 23, 2022 | News, Open Content

The precision medicine company recently announced a pair of strategic alliances aimed at expanding access to new cancer diagnostics.

« Older Entries

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com